Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

in vitro

  • Open Access
    Recombinant Methioninase (rMETase) Synergistically Sensitizes Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose Ivermectin
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, CHIHIRO HOZUMI, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research February 2025, 45 (2) 451-455; DOI: https://doi.org/10.21873/anticanres.17434
  • Open Access
    Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG M. KANG, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research November 2024, 44 (11) 4773-4778; DOI: https://doi.org/10.21873/anticanres.17303
  • Open Access
    Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts
    SEI MORINAGA, QINGHONG HAN, YUTARO KUBOTA, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research March 2024, 44 (3) 921-928; DOI: https://doi.org/10.21873/anticanres.16886
  • You have access
    Attempt to Construct an In Vitro Model of Enhancement of Macrophage Phagocytosis Via Continuous Administration of LPS
    KAZUSHI YAMAMOTO, HARUKA MIZOBUCHI, MASASHI YAMASHITA, HIROYUKI INAGAWA, CHIE KOHCHI and GEN-ICHIRO SOMA
    Anticancer Research August 2020, 40 (8) 4711-4717; DOI: https://doi.org/10.21873/anticanres.14472
  • You have access
    Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Ovarian Cancer Cells In Vitro
    TEA KUITTINEN, PÄIVI ROVIO, TIINA LUUKKAALA, MARITA LAURILA, SEIJA GRÉNMAN, ANNE KALLIONIEMI and JOHANNA MÄENPÄÄ
    Anticancer Research June 2020, 40 (6) 3129-3138; DOI: https://doi.org/10.21873/anticanres.14294
  • You have access
    A Brief Guide to Performing Pharmacological Studies In Vitro: Reflections from the EORTC-PAMM Course “Preclinical and Early-phase Clinical Pharmacology”
    MJRIAM CAPULA, CRISTINA CORNO, BTISSAME EL HASSOUNI, GIOVANNA LI PETRI, SANDRA ARANĐELOVIĆ and on Behalf of the EORTC PAMM Group
    Anticancer Research July 2019, 39 (7) 3413-3418; DOI: https://doi.org/10.21873/anticanres.13485
  • You have access
    Effective Metabolic Targeting of Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models with Recombinant Methioninase
    KENTARO IGARASHI, KEI KAWAGUCHI, TASUKU KIYUNA, KENTARO MIYAKE, TAKASHI MURAKAMI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN
    Anticancer Research September 2017, 37 (9) 4807-4812;
  • You have access
    Moesin Expression Is Associated with Glioblastoma Cell Proliferation and Invasion
    QING WANG, XIAOJIE LU, SHIDI ZHAO, MINGZHI PANG, XUECHAO WU, HENG WU, ROBERT M. HOFFMAN, ZHIJIAN YANG and YAN ZHANG
    Anticancer Research May 2017, 37 (5) 2211-2218;
  • You have access
    Non-toxic Efficacy of the Combination of Caffeine and Valproic Acid on Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models
    KENTARO IGARASHI, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, HIROAKI KIMURA, SHINJI MIWA, ROBERT M. HOFFMAN and HIROYUKI TSUCHIYA
    Anticancer Research September 2016, 36 (9) 4477-4482;
  • You have access
    Radiosensitivity Uncertainty Evaluation for the In Vitro Biophysical Modeling of EMT6 Cells
    MASATAKA OITA, YOSHIHIRO UTO, MASAHIDE TOMINAGA, MOTOHARU SASAKI, YASUO HARA, TARO KISHI and HITOSHI HORI
    Anticancer Research August 2014, 34 (8) 4621-4626;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire